Experimental models and tools to tackle glioblastoma
Glioblastoma multiforme (GBM) is one of the deadliest human cancers. Despite increasing knowledge of the genetic and epigenetic changes that underlie tumour initiation and growth, the prognosis for GBM patients remains dismal. Genome analysis has failed to lead to success in the clinic. Fresh approa...
Main Authors: | Faye L. Robertson, Maria-Angeles Marqués-Torrejón, Gillian M. Morrison, Steven M. Pollard |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2019-09-01
|
Series: | Disease Models & Mechanisms |
Subjects: | |
Online Access: | http://dmm.biologists.org/content/12/9/dmm040386 |
Similar Items
-
Applications of CRISPR-Cas9 Technology to Genome Editing in Glioblastoma Multiforme
by: Nadia Al-Sammarraie, et al.
Published: (2021-09-01) -
Inducible Genome Editing with Conditional CRISPR/Cas9 Mice
by: Alexandra Katigbak, et al.
Published: (2018-05-01) -
Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in Glioblastoma
by: Kai Huang, et al.
Published: (2019-09-01) -
Generation of Glioblastoma Patient-Derived Intracranial Xenografts for Preclinical Studies
by: Amber E. Kerstetter-Fogle, et al.
Published: (2020-07-01) -
In vivo genome editing in mouse restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers
by: Menglong Chen, et al.
Published: (2021-04-01)